Oncimmune Holdings plc named Adam Hill as its chief medical and chief strategy officer.

Hill, who will assume the positions April 9, most recently worked with McLaren Applied Technologies in a similar capacity.

He is also the former chief medical officer of Sectra AB.

Nottingham, U.K.-based Oncimmune is looking to commercialize its EarlyCDT platform to detect cancer.